David Jollow to In Vitro Techniques
This is a "connection" page, showing publications David Jollow has written about In Vitro Techniques.
Connection Strength
0.326
-
Lipids versus proteins as major targets of pro-oxidant, direct-acting hemolytic agents. Toxicol Sci. 2005 Nov; 88(1):274-83.
Score: 0.061
-
Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline. J Pharmacol Exp Ther. 2001 May; 297(2):509-15.
Score: 0.046
-
Chemical analysis and hemolytic activity of the fava bean aglycon divicine. Chem Res Toxicol. 1993 Jul-Aug; 6(4):439-44.
Score: 0.026
-
Arylamine-induced hemolytic anemia: electron spin resonance spectrometry studies. Adv Exp Med Biol. 1991; 283:253-5.
Score: 0.022
-
Contribution of 3,4-dichlorophenylhydroxylamine in propanil-induced hemolytic anemia. Adv Exp Med Biol. 1991; 283:343-5.
Score: 0.022
-
Relationship between sulfotransferase activity and susceptibility to acetaminophen-induced liver necrosis in the hamster. Drug Metab Dispos. 1987 Mar-Apr; 15(2):143-50.
Score: 0.017
-
Use of the NIH shift to determine the relative contribution of competing pathways of aniline metabolism in the rat. Drug Metab Dispos. 1986 Nov-Dec; 14(6):689-91.
Score: 0.017
-
Application of cryopreserved human hepatocytes in trichloroethylene risk assessment: relative disposition of chloral hydrate to trichloroacetate and trichloroethanol. Environ Health Perspect. 2006 Aug; 114(8):1237-42.
Score: 0.016
-
Acetaminophen hepatotoxicity: studies on the mechanism of cysteamine protection. Toxicol Appl Pharmacol. 1986 Mar 30; 83(1):115-25.
Score: 0.016
-
The mechanisms of cobalt chloride-induced protection against acetaminophen hepatotoxicity. Drug Metab Dispos. 1986 Jan-Feb; 14(1):25-33.
Score: 0.016
-
Primaquine-induced hemolytic anemia: role of membrane lipid peroxidation and cytoskeletal protein alterations in the hemotoxicity of 5-hydroxyprimaquine. J Pharmacol Exp Ther. 2005 Aug; 314(2):838-45.
Score: 0.015
-
Effect of L-ascorbic acid on acetaminophen-induced hepatotoxicity and covalent binding in hamsters. Evidence that in vitro covalent binding differs from that in vivo. Drug Metab Dispos. 1984 May-Jun; 12(3):271-9.
Score: 0.014
-
Glutathione thresholds in reactive metabolite toxicity. Arch Toxicol Suppl. 1980; 3:95-110.
Score: 0.010
-
Metabolic activation of furosemide to a chemically reactive, hepatotoxic metabolite. J Pharmacol Exp Ther. 1976 Oct; 199(1):41-52.
Score: 0.008
-
Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology. 1974; 11(3):151-69.
Score: 0.007
-
Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther. 1973 Oct; 187(1):195-202.
Score: 0.007
-
Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro. J Pharmacol Exp Ther. 1973 Oct; 187(1):203-10.
Score: 0.002
-
Role of detoxifying enzymes in bromobenzene-induced liver necrosis. J Pharmacol Exp Ther. 1973 Oct; 187(1):218-27.
Score: 0.002
-
The role of cytochrome P-450 in N-hydroxylation of 2-acetylaminofluorene. Mol Pharmacol. 1973 May; 9(3):398-404.
Score: 0.002